๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Squamous-cell carcinoma of the floor of the mouth

โœ Scribed by Crissman, John D. ;Gluckman, Jack ;Whiteley, Joseph ;Quenelle, David


Publisher
Wiley (John Wiley & Sons)
Year
1980
Weight
570 KB
Volume
3
Category
Article
ISSN
0148-6403

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Among the histologic parameters described by Jakobsson, only the stage (depth) of invasion appears to be of value in predicting lymph node metastases. Early carcinomas of the FOM examined in our institution (T1 and some T2) grew in a superficial or horizontal manner and none developed metastases or local recurrence. Larger neoplasms (some T2 and all T3 and T4) had extensive submucosal and deep soft tissue infiltration and a corresponding high frequency of regional lymph node metastases. T1 and T2 neoplasms with only superficial or microinvasion of the submucosa have little or no propensity for lymph node metastases, while T2 cancers with nodular or vertical infiltration into the submucosa have a substantial frequency of metastatic disease (44%). If the biopsy sites are carefully selected, these growth patterns can be identified by the pathologist. In addition, our experience is that clinical assessment of cervical lymph nodes for the presence of metastatic disease is often erroneous. Rates of 56% false positives and 24% false negatives were observed, which were similar to rates reported in other series. Biopsy evaluation of the extent and growth pattern of the primary neoplasm is as important as physical examination in determining the type of surgery to be done and whether lymph node dissection should be performed.


๐Ÿ“œ SIMILAR VOLUMES


Management of squamous cell carcinoma of
โœ Drs. Lawrence W. Rodgers Jr.; Dr. Scott P. Stringer; William M. Mendenhall; Jame ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 397 KB ๐Ÿ‘ 1 views

Between 1964 and 1987, 194 patients with previously untreated squamous cell carcinoma of the floor of mouth were managed at the University of Florida. A retrospective analysis was undertaken in order to evaluate the treatment results and associated complication rates. Surgery or irradiation alone w

Squamous cell carcinoma of the floor of
โœ Wesley L. Hicks Jr; Thom R. Loree; Rafael I. Garcia; Sherif Maamoun; Dori Marsha ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 191 KB ๐Ÿ‘ 2 views

Background. This study retrospectively examines our treatment choices and outcomes with patients diagnosed with squamous cell cancer of the floor of mouth. Because of our division's past strong surgical bias in the treatment of this disease, we have assessed the results of a patient population treat

Metastatic spread of floor of the mouth
โœ Prof. F. Badellino; P. Berrino; E. Campora; G. Canavese; A. Galli; G. Margarino; ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 376 KB ๐Ÿ‘ 1 views

In a patient with recurrent head and neck squamous cell carcinoma, reconstruction of the floor of the mouth was carried out by transposition of a pectoralis major myocutaneous flap after composite resection. Twelve months after surgery, a chest wall metastasis corresponding to the site of the vascul

Prediction of cervical lymph node metast
โœ Dr. Julia A. Woolgar; John Scott ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 899 KB

Background. Cervical lymph node metastasis has a major influence on survival in oral cancer. However, the factors influencing its occurrence are uncertain. Our aim was to improve the prognostic efficiency of the histologic assessment of the primary tumor in predicting metastasis in an individual pat

Effectiveness of routine follow-up of pa
โœ Matthias Adrianus Wilhelmus Merkx; Joris Jan Martijn van Gulick; Henri August Ma ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 1 views

## Background: The duration of follow-up after treatment for head and neck cancer, the depth of the routine visits, and the diagnostic tools used are determined on the basis of common acceptance rather than evidence-based practice. patients with early-stage tumors are more likely to benefit from fo